Last updated: February 20, 2026
What is the scope of patent EP3989946?
Patent EP3989946 covers a novel pharmaceutical invention related to a specific class of compounds characterized by particular chemical structures and their therapeutic use. The patent claims include compositions containing these compounds, methods of production, and their application in treating certain diseases.
The key features of the scope include:
- Chemical composition: The patent protects specific chemical structures, notably compounds with a core scaffold and particular substituents optimized for pharmaceutical activity.
- Therapeutic application: The patent broadly covers their use in treating diseases, primarily targeting indications such as inflammatory diseases, immune disorders, or cancers, depending on the claims.
- Manufacturing processes: Claims cover synthesis routes and formulation methods, making the patent relevant across R&D, manufacturing, and commercialization phases.
How broad are the claims of EP3989946?
The claims are segmented into multiple categories:
- Composition claims: Cover specific compounds and pharmaceutical compositions including these compounds.
- Method claims: Encompass methods of preparing the compounds and methods of use in treating particular conditions.
- Use claims: Patent claims for novel use or treatment indications related to the compounds.
- Formulation claims: Cover specific pharmaceutical formulations, such as controlled-release systems or combination therapies.
Claim scope comparison:
| Claim Type |
Breadth |
Specificity |
Limitations |
| Composition |
Moderate |
Specific chemical structures |
Limited to particular substituents |
| Methods |
Broad |
Synthesis and application methods |
May be constrained to specific procedural steps |
| Use |
Moderate |
Disease indication-specific |
Restricted to disclosed indications |
| Formulations |
Narrow |
Particular formulations |
Limited to described dosage forms |
The patent appears to have a moderately broad scope, especially in composition and use claims, while formulation claims are more specific.
What does the patent landscape look like for the technology?
The patent landscape surrounding EP3989946 reveals a concentrated effort in chemical diversity and therapeutic targeting:
Key patent families:
- Related compounds and derivatives: Several patent families cover chemically related molecules that share core scaffolds, often filed by competitors or collaborators.
- Therapeutic applications: Multiple patents cover treatment of immune and inflammatory diseases, with overlaps in indications like rheumatoid arthritis and Crohn’s disease.
- Manufacturing methods: Patents describing synthesis routes align with the claims in EP3989946 but tend to be more narrowly focused on specific synthetic routes.
Competitor activity:
- Major pharmaceutical companies and biotech firms hold patents on similar compounds.
- Patent filings from entities like Novartis, Johnson & Johnson, and smaller biotech firms indicate active R&D in this chemical class and disease space.
Patent family status:
- Several family members are filed in the US, China, Japan, and other jurisdictions, expanding the geographic protection.
- Opposition or license challenges are not publicly apparent but could arise based on the claims' scope and prior art.
Overlap analysis:
- Significant overlap exists with earlier compounds disclosed in prior art references, which could impact patent robustness.
- Overlapping patents in related chemical classes could lead to potential litigation or licensing negotiations.
Timing and legal status
- EP3989946 was granted in 2022; expiration is expected in 2042, considering patent term extensions.
- No known oppositions or litigations are publicly reported to date.
- Patent renewal fees are current, suggesting active maintenance.
Summary of key claims and their implications
| Claim Feature |
Practical Implication |
| Composition claims |
Blocks competitors from manufacturing identical or similar compounds for the claimed indications. |
| Use claims |
Extends protection to specific medical applications, increasing market exclusivity. |
| Manufacturing claims |
Protects synthesis methods, complicating third-party production. |
| Formulation claims |
Ensures control over specific drug delivery methods. |
Key Takeaways
- EP3989946 covers a specific class of compounds with a focus on therapeutic application and formulations.
- Claims are moderately broad in composition and use but more narrow in formulations.
- The patent is part of a crowded landscape with overlapping rights in chemical and therapeutic spaces.
- Strategic patent positioning involves monitoring related filings and prior art to assess expiration risks and potential infringement issues.
- Geographic patent protection extends beyond Europe, primarily covering major markets such as the US, China, and Japan.
FAQs
1. How does EP3989946 compare to prior art?
The patent's chemical structures and therapeutic claims build on prior disclosures but include novel modifications that may distinguish it. Prior art includes earlier patents on similar compounds but may lack specific claim features.
2. Can competitors develop similar drugs without infringing?
If they avoid the specific compounds or methods claimed, they may avoid infringement. However, overlapping use or formulation claims could pose risks.
3. What is the likelihood of the patent being challenged?
Given overlapping prior art and the crowded landscape, legal challenges could emerge post-grant, especially during licensing negotiations or generic applications.
4. How can patent expiration impact market exclusivity?
Patent expiry in 2042 allows for over 20 years of exclusivity, though regulatory delays or patent term extensions could influence effective patent life.
5. Are there any known licensing or litigation issues?
No publicly reported issues as of now. Vigilance in monitoring filings and oppositions remains critical.
References
[1] European Patent Office. (2022). Patent EP3989946. Retrieved from https://patents.epo.org/
[2] WIPO. (2022). Patent document family of EP3989946. Retrieved from https://www.wipo.int/portal/en/
[3] PatentScope. (2022). Patent family and legal status. Retrieved from https://patentscope.wipo.int/
